India's FDC rises most in 2 months on completion of US FDA inspection

FDC

27/03/2023 08:42

** Shares of pharma and consumer healthcare co FDC Ltd
 FDC.NS  rise as much as 4.4% to 266 rupees, biggest pct gain
since Jan. 31
    **  Co on Monday reported that its manufacturing unit at
Maharashtra was inspected by US FDA from 20th March 2023 to 24th
March 2023 and has been successfully completed with "no
observations"
    ** The Active Pharmaceutical Ingredient's product
manufactured at the unit continues to be marketed in USA
    ** More than 128,630 shares change hands by 01:10 p.m. IST
vs 1.9x 30-day avg of 67,600 shares
    ** Median PT is 350 rupees - Refinitiv data
    ** Stock down 5.9% YTD up to last close

 (Reporting by Ashna Teresa Britto in Bengaluru)
 ((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))